CHE199474643Chemin du Champ-Baron 3, 1209 Genève
Nirkana Sàrl is a Swiss GmbH based in Genève, active in the commercial register.▍
A visual read of this company's public register record.
Nirkana Sàrl, GmbH · Genève · Genève
Ask about this company
Chat with an AI about this company, grounded in the official register.
Upgrade to ProCHF 29 / month
Search the public web for recent coverage of this company.
Sign in to see recent web coverageClick any node to explore its connections.
Unlock with Pro
Monitor this company for register changes, get alerts, and draft outreach with AI.
Upgrade to ProCHF 29 / month
l'exercice de toutes activités liées aux plantes médicinales et leurs dérivés, y compris le cannabidiol; la conception, la production et le conditionnement de produits issus de ces substances. Elle a également pour but la fabrication et la commercialisation de produits pharmaceutiques, sanitaires, cosmétiques et alimentaires, notamment de…
Recent commercial-register publications (SOGC).
Nirkana Sàrl , à Genève , CHE-199.474.643 (FOSC du 25.11.2025, p. 0/1006494478). Les associés-gérants Conde Rodrigues José et Baqué Oscar signent désormais individuellement.
Nirkana Sàrl , à Genève , Chemin du Champ-Baron 3, c/o José Conde Rodrigues, 1209 Genève, CHE-199.474.643 . Nouvelle société à responsabilité limitée. Statuts du 04.11.2025. But: l'exercice de toutes activités liées aux plantes médicinales et leurs dérivés, y
Officers not yet extracted for this company. See the official extract for the full board.
Same sector, nearby first.
Is this your company? Embed this badge on your site. It shows your entry in the Swiss commercial register and links to your live dossier.
<a href="https://regista.ch/research/c/CHE199474643" target="_blank" rel="noopener"><img src="https://regista.ch/api/badge/CHE199474643" width="320" height="72" alt="Swiss commercial register entry" /></a>
Company facts reflect public commercial-register data. Officer and relationship data is derived from published register text. Register data as of 30 July 2026.